Founded in 1964, New York Blood Center (NYBC) has served the tri-state area for more than 60 years, delivering 500,000 lifesaving blood products annually to 150+ hospitals, EMS and healthcare partners. NYBC is part of New York Blood Center Enterprises (NYBCe), which spans 17+ states and delivers one million blood products to 400+ U.S. hospitals annually. NYBCe additionally delivers cellular therapies, specialty pharmacy, and medical services to 200+ research, academic and biopharmaceutical organizations. NYBCe’s Lindsley F. Kimball Research Institute is a leader in hematology and transfusion medicine research, dedicated to the study, prevention, treatment and cure of bloodborne and blood-related diseases. NYBC serves as a vital community lifeline dedicated to helping patients and advancing global public health. To learn more, visit nybc.org. Connect with us on Facebook, X, Instagram, and LinkedIn. 

Founded in 1954, Blood Bank of Delmarva (BBD) has served the Delmarva Peninsula for 70 years, delivering nearly 90,000 lifesaving blood products annually to 40+ hospitals, EMS and healthcare partners. BBD is part of New York Blood Center Enterprises (NYBCe), which spans 17+ states and delivers one million blood products to 400+ U.S. hospitals annually. NYBCe additionally delivers cellular therapies, specialty pharmacy, and medical services to 200+ research, academic and biopharmaceutical organizations. NYBCe’s Lindsley F. Kimball Research Institute is a leader in hematology and transfusion medicine research, dedicated to the study, prevention, treatment and cure of bloodborne and blood-related diseases. BBD serves as a vital community lifeline dedicated to helping patients and advancing global public health. To learn more, visit delmarvablood.org. Connect with us on Facebook, X, Instagram, and LinkedIn.

Founded in 1958, Community Blood Center (CBC) has served Kansas and Missouri for more than 65 years, delivering more than 150,000 lifesaving blood products annually to 70+ hospitals, EMS and healthcare partners. CBC is part of New York Blood Center Enterprises (NYBCe), which spans 17+ states and delivers one million blood products to 400+ U.S. hospitals annually. NYBCe additionally delivers cellular therapies, specialty pharmacy, and medical services to 200+ research, academic and biopharmaceutical organizations. NYBCe’s Lindsley F. Kimball Research Institute is a leader in hematology and transfusion medicine research, dedicated to the study, prevention, treatment, and cure of bloodborne and blood-related diseases. CBC serves as a vital community lifeline dedicated to helping patients and advancing global public health. To learn more, visit savealifenow.org. Connect with us on Facebook, X, Instagram, and LinkedIn.

Innovative Blood Resources is a nonprofit community blood center that was formed in 2012 through the combination of two strong, nationally-recognized, community-based nonprofit blood centers: Minnesota-based Memorial Blood Centers, and Nebraska Community Blood Bank. With a combined 100 years of blood industry experience, IBR provides comprehensive product and service capabilities focusing on value-driven solutions for patients, hospitals, physicians, researchers, and other healthcare partners.

IBR is also home to IBR Biomedical Services, which grew from the nationally recognized research and clinical trial contributions of Memorial Blood Centers’ physicians and clinicians in blood banking and transfusion services. IBR Biomedical Services offers expertise in the areas of cellular therapy, clinical trial support, as well as regulatory and quality systems consulting.
innovativebloodresources.org

Founded in 1948, Memorial Blood Centers have served Minnesota and Wisconsin for more than 75 years, delivering more than 125,000 lifesaving blood products annually to 50+ hospitals, EMS and healthcare partners. MBC is part of New York Blood Center Enterprises (NYBCe), which spans 17+ states and delivers one million blood products to 400+ U.S. hospitals annually. NYBCe additionally delivers cellular therapies, specialty pharmacy, and medical services to 200+ research, academic and biopharmaceutical organizations. NYBCe’s Lindsley F. Kimball Research Institute is a leader in hematology and transfusion medicine research, dedicated to the study, prevention, treatment and cure of bloodborne and blood-related diseases. MBC serves as a vital community lifeline dedicated to helping patients and advancing global public health. To learn more, visit mbc.org. Connect with us on Facebook, X, Instagram, and LinkedIn.

Founded in 1968, Nebraska Community Blood Bank (NCBB) has served Nebraska and western Iowa for more than 50 years, delivering more than 60,000 lifesaving blood products annually to 25+ hospitals, EMS and healthcare partners. NCBB is part of New York Blood Center Enterprises (NYBCe), which spans 17+ states and delivers one million blood products to 400+ U.S. hospitals annually. NYBCe additionally delivers cellular therapies, specialty pharmacy, and medical services to 200+ research, academic and biopharmaceutical organizations. NYBCe’s Lindsley F. Kimball Research Institute is a leader in hematology and transfusion medicine research, dedicated to the study, prevention, treatment and cure of bloodborne and blood-related diseases. NCBB serves as a vital community lifeline dedicated to helping patients and advancing global public health. To learn more, visit ncbb.org. Connect with us on Facebook, X, Instagram, and LinkedIn.

Founded in 1979, Rhode Island Blood Center (RIBC) has served Rhode Island and the New England area for more than 45 years, delivering more than 90,000 lifesaving blood products annually to 50+ hospitals, EMS and healthcare partners. RIBC is part of New York Blood Center Enterprises (NYBCe), which spans 17+ states and delivers one million blood products to 400+ U.S. hospitals annually. NYBCe additionally delivers cellular therapies, specialty pharmacy, and medical services to 200+ research, academic and biopharmaceutical organizations. NYBCe’s Lindsley F. Kimball Research Institute is a leader in hematology and transfusion medicine research, dedicated to the study, prevention, treatment and cure of bloodborne and blood-related diseases. RIBC serves as a vital community lifeline dedicated to helping patients and advancing global public health. To learn more, visit ribc.org. Connect with us on Facebook, X, Instagram, and LinkedIn.

Connecticut Blood Center (CTBC) serves as the primary supplier of lifesaving blood products to more than a dozen Connecticut hospitals, EMS and healthcare partners. CTBC is operated by Rhode Island Blood Center and is part of New York Blood Center Enterprises (NYBCe), which spans 17+ states and delivers one million blood products to 400+ U.S. hospitals annually. NYBCe additionally delivers cellular therapies, specialty pharmacy, and medical services to 200+ research, academic and biopharmaceutical organizations. NYBCe’s Lindsley F. Kimball Research Institute is a leader in hematology and transfusion medicine research, dedicated to the study, prevention, treatment, and cure of bloodborne and blood-related diseases. CTBC serves as a vital community lifeline dedicated to helping patients and advancing global public health. To learn more, visit ctblood.org. Connect with us on Facebook, X, Instagram, and LinkedIn.

Comprehensive Cell Solutions (CCS), a business unit of New York Blood Center Enterprises, is a cell and gene therapy-focused development and manufacturing organization that provides critical capacity to early-stage developers, as well as expertise and strategic footprint for hospital treatment centers and pharmaceutical organizations. Headquartered in New York, CCS provides a true Draw-to-Thaw™ solution, spanning fresh cellular collections and cord-blood derived stem cells as source material, to cell isolation, manipulation and cryopreservation capabilities for preclinical to commercial stage products. CCS boasts a client roster composed of the world’s leading pharmaceutical companies, innovative biotechnology organizations and academic medical centers. CCS also performs cellular collections, clinical apheresis and CGT manufacturing services.
Comprehensive Cell Solutions

Founded in 1974, New York Blood Center Enterprises’ Lindsley F. Kimball Research Institute is a leading center for basic and applied research in hematology and transfusion medicine. LFKRI researchers are dedicated to the study of blood and the prevention, treatment and cure of bloodborne and blood-related diseases, making major contributions toward understanding and combating a wide variety of diseases such as AIDS, hepatitis, COVID, malaria, sickle cell disease, and leukemia, making it possible for thousands of people to live healthier lives. The work of LFKRI’s principal investigators is made possible by support from NYBCe, together with approximately $12M to $16M per year in grant funding and contracts primarily from the National Institutes of Health (NIH). The Institute’s commitment to groundbreaking research has resulted in numerous landmark patents and licenses but also making it possible for thousands of people to live healthier lives. LFKRI’s areas of blood-related research include transfusion medicine, hematology, infectious disease, epidemiology, and cellular therapy.
Lindsley F. Kimball Research Institute

The National Center for Blood Group Genomics (NCBGG), a part of New York Blood Center Enterprises, is a research hub specializing in applying precision medicine to blood transfusion to increase safety and minimize complications. Headquartered in Kansas City, MO, NCBGG specializes in providing PreciseMatch blood products nationwide to avoid complications, properly screen patients for the suitability of various transfusion treatment regimens and improve transfusion medicine’s overall practice and safety. Its genomics research helps match patients and blood donors to better treat hematological malignancies, inherited, and acquired anemias, autoimmune diseases, and transplantation when selecting products for transfusion.
bloodgroupgenomics.org

NYBC corporate publications reflect our commitment to standards, policies, and procedures that ensure we continue to achieve our mission and maintain our core values of quality, excellence, service, leadership, respect, innovation, compassion, integrity, maintaining public trust, and sharing knowledge.

• Community Report (PDF)
• NYBC Certificate of Incorporation
• NYBC Bylaws
• Board COI and Confidentiality Policy